|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Left ventricular resynct- nization is mandatory for response to cardiac resynchonization therapy :anysis in patients with echocardiographic evidence of left ventricular dyssynctu'ony at baseline 显示文摘 | Gabe B Sjoerd A Eduard R et | 2007 | Circulation2007,116,: | 1 |
| 2 | Mechanism of the selective catalytic reduction of NO with NH3 over MnOx/Al2O3: II Reactivity of adsorbed NH3 and NO complexes 显示文摘 | SJOERD K W BRANDS D S SMIT H I POELS E K BLIEK A | 1997 | J Catal1997,171,1: | 1 |
| 3 | Evaluation of diagnostic NOTCH3 immunostaining in CADASIL 显示文摘 | Saskia A J Lesnik Oberstein Sjoerd G | 2003 | Acta Neuropathol2003,106,: | 1 |
| 4 | Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications显示文摘 | Sjoerd A Pieter V Jan Willem C | 2015 | Expert Rev Clin lmmunol2015,11,4: | 1 |
| 5 | Mechanism of the selective catalytic reduction of NO with NH3 over MnOx/Al2O3 : I Adsorption and desorption of the single reaction components显示文摘 | SJOERD K W BRANDS D S POELS E K BLIEK A | 1997 | J Catal1997,171,1: | 1 |
| 6 | Saliency in a suppressed image affects the spatial origin of perceptual alternations during binocular rivalry 显示文摘 | SJOERD M S FRANS A V CHRIS L P | 2010 | Vision Research2010,50,19: | 1 |
| 7 | 青霉素治疗儿童急性咽喉痛:随机、双盲临床试验显示文摘目的 对于小儿咽喉痛患者,应用青霉素治疗3天和7天,并与安慰剂相对照,以评价青霉素的疗效。 设计 随机、双盲、安慰剂对照试验。 设置 荷兰的43所全科医疗诊所。 对象 156例4~15岁的患儿,具咽喉痛症状<7天;至少符合4项主要诊断标准中的2项(有发热病史;无咳嗽;颈前淋巴结轻度肿大;扁桃体可见分泌物)。 干预措施 将病人随机分为3组:青霉素治疗7天组、青霉素治疗3天继而服用安慰剂4天组、安慰剂服用7天组。 衡量结局的主要指标 症状持续的时间;平均使用止痛剂的时间;因病休课的天数;链球菌感染后遗症的发生率;对病原体的根除率及6个月后咽痛的再发率。 结果 应用青霉素治疗咽喉痛患儿,与安慰剂比较并无明显优势,无论是对参与试验的所有患儿还是对有A组链球菌感染的96名患儿。随机分到青霉素治疗7天组有1名患儿出现了链球菌感染后遗症;青霉素治疗3天后继用安慰剂组有2例,而服用安慰剂7天组有8例患儿出现链球菌感染后遗症。 结论 在小儿咽喉疼痛平均持续时间方面,青霉素治疗并无明显优势。但是,它可能降低链球菌感染后遗症的发生率。 | Sjoerd Zwart Maroeska M Rovers Ruut A de Melker Arno W Hoes | 2004 | 英国医学杂志中文版2004,7,3: | 1 |
| 8 | Induced resistance orchestrating defence mechanisms through crosstalking and priming 显示文摘 | Sjoerd V E Koorrmeef A Jurriaan T | 2009 | Annual Plant Reviews2009,34,: | 1 |
| 9 | Identification of Clinical Outcome Measures for Recovery of Gastrointestinal Motility in Postoperative Ileus 显示文摘 | Sjoerd HW Van Bree Willem A | 2014 | Annals of Surgery2014,259,4: | 1 |
| 10 | Porosity-permeability properties generated with a new 2-parameter 3D hydraulic pore-network model for consolidated and unconsolidated porous media显示文摘 | Acharya R C Sjoerd E A T M van der Zee Leijinse Anton | 2004 | Advances in Water Resources2004,,27: | 1 |
| 11 | Can bedside needle arthroscopy of the ankle be an accurate option for intra-articular delivery of injectable agents?显示文摘BACKGROUND Bedside needle arthroscopy of the ankle under local anesthesia has been proposed for intra-articular delivery of injectable agents.Accuracy and tolerability of this approach in the clinical setting–including patients with end-stage ankle pathology and/or a history of prior surgery–is not known.AIM To assess clinical accuracy and tolerability of bedside needle arthroscopy as a delivery system for injectable agents into the tibiotalar joint.METHODS This was a prospective study that included adult patients who were scheduled for an injection with hyaluronic acid to the tibiotalar joint.In our center,these injections are used as a last resort prior to extensive surgery.The primary outcome was injection accuracy,which was defined as injecting through the arthroscopic cannula with intra-articular positioning confirmed by a clear arthroscopic view of the joint space.Secondary outcome measures included a patientreported numeric rating scale(NRS,0-10)of pain during the procedure and willingness of patients to return for the same procedure.NRS of ankle pain at rest and during walking was collected at baseline and at 2-wk follow-up.Complications were monitored from inclusion up to a 2-wk control visit.RESULTS We performed 24 inspection-injections.Eleven(46%)participants were male,and mean age was 46.8±14.5 years.Osteoarthritis was the indication for injection in 20(83%)cases,of which 8(33%)patients suffered from osteoarthritis Kellgren-Lawrence grade IV,and 10(42%)patients from Kellgren-Lawrence grade III.An osteochondral defect was the indication for injection in 4(17%)cases.A history of ankle surgery was present in 14(58%)participants and a history of multiple ankle surgeries in 11(46%)participants.It was possible to confirm accuracy in 21(88%)procedures.The 3(12%)participants where needle arthroscopy did not reach a clear view of the joint space all suffered from Kellgren-Lawrence grade IV osteoarthritis.Pain during the procedure was reported with a median of 1[interquartile ranges(IQR):0–2].Willingness to return was 100%.Pain in rest decreased from a median NRS of 4(IQR:2–7)at baseline to a median of 3(IQR:1–5)at follow-up(P<0.01).Pain during walking decreased from a median NRS of 8(IQR:6–9)to a median of 7(IQR:4–8)(P<0.01).Infections or other complications were not encountered.CONCLUSION Clinical accuracy and tolerability of bedside needle arthroscopy of the ankle as a delivery system for injectable agents are excellent.Accuracy was 100%in patients without total ventral joint obliteration. | Tobias Stornebrink Sjoerd A S Stufkens Nathaniel P Mercer John G Kennedy Gino M M J Kerkhoffs | 2022 | World Journal of Orthopedics2022,13,1: | 1 |
| 12 | Clinical efficacy of the Ankle Spacer for the treatment of multiple secondary osteochondral lesions of the talus显示文摘BACKGROUND The Ankle Spacer was developed as a joint-sparing alternative to invasive endstage surgeries.Currently,there are no clinical studies on the Ankle Spacer.AIM To describe the operative technique and the clinical efficacy of the Ankle Spacer for the treatment of multiple,cystic osteochondral lesions of the talus in patients with failed prior operative treatment.METHODS This is a prospective study during which patients were assessed preoperatively,at 2-and 6 wk,and at 3,6,12 and 24 mo postoperatively.Patients with multiple,cystic or large(≥15 mm)osteochondral lesions of the talus after failed prior surgery were included.The primary outcome measure was the numeric rating scale(NRS)for pain during walking at 2 years postoperatively.Secondary outcome measures included the NRS in rest and during stair climbing,the American Orthopaedic Foot and Ankle Society Hindfoot Score,the Foot and Ankle Outcome Score,the Short-Form 36 physical and mental component scale,and the Range of Motion(ROM).Radiographic evaluations were conducted to evaluate prosthetic loosening and subsidence.Revision rates and complications were also assessed.RESULTS Two patients underwent an Ankle Spacer implantation on the talus.The NRS during walking improved from 6 and 7 preoperatively to 2 and 2 points postoperatively at 2 years,in patient 1 and 2,respectively.The other patient-reported outcome measures also improved substantially.There were no re-operations nor complications.Radiological imaging showed no loosening of the implant and no change of implant position.CONCLUSION The Ankle Spacer showed clinically relevant pain reduction during walking,improvement in clinical outcomes as assessed with PROMs,and no complications or re-operations.This treatment option may evolve as a joint-sparing alternative to invasive end-stage surgeries. | Jari Dahmen J Nienke Altink Gwendolyn Vuurberg Coen A Wijdicks Sjoerd AS Stufkens Gino MMJ Kerkhoffs | 2022 | World Journal of Orthopedics2022,13,2: | 0 |